Search research articles
Contact Us
Filters
Showing results (381-390 of 432) with videos related to
Page
of 44
Sort By:
Molecular Neurodegeneration
|
February 16, 2019
Aberrant deposition of stress granule-resident proteins linked to C9orf72-associated TDP-43 proteinopathy
Jeannie Chew, Casey Cook, Tania F Gendron, et al.
Nature Genetics
|
January 24, 2006
Spectrin mutations cause spinocerebellar ataxia type 5
Yoshio Ikeda, Katherine A Dick, Marcy R Weatherspoon, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 18, 2026
Functional Activity of TDP-43: A Direct Biomarker for ALS
Kirti Shila Sonkar, Vito Levi D'Ancona, Jade Cramp, et al.
Brain : a Journal of Neurology
|
April 12, 2024
Apilimod dimesylate in C9orf72 amyotrophic lateral sclerosis: a randomized phase 2a clinical trial
Suma Babu, Katharine A Nicholson, Jeffrey D Rothstein, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
November 10, 2006
Amyotrophic lateral sclerosis 2-deficiency leads to neuronal degeneration in amyotrophic lateral sclerosis through altered AMPA receptor trafficking
Chen Lai, Chengsong Xie, Stefanie G McCormack, et al.
Nature Neuroscience
|
December 10, 2013
Identification of a unique TGF-β-dependent molecular and functional signature in microglia
Oleg Butovsky, Mark P Jedrychowski, Craig S Moore, et al.
The American Journal of Tropical Medicine and Hygiene
|
December 10, 2024
Evaluation of the Performance of Portable Hemoglobinometers at Measuring Hemoglobin and Detecting Anemia in a Periurban Pediatric Population in Lima, Peru
Zach Silverstein, Alicia Alva Mantari, Kimberly Breglio, et al.
Plos One
|
April 25, 2013
Design and initial results of a multi-phase randomized trial of ceftriaxone in amyotrophic lateral sclerosis
James D Berry, Jeremy M Shefner, Robin Conwit, et al.
The Lancet. Neurology
|
October 10, 2014
Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial
Merit E Cudkowicz, Sarah Titus, Marianne Kearney, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 12, 2016
Motor neuron disease, TDP-43 pathology, and memory deficits in mice expressing ALS-FTD-linked UBQLN2 mutations
Nhat T T Le, Lydia Chang, Irina Kovlyagina, et al.
Page
of 44
Search research articles
Search
Showing results (381-390 of 432) with videos related to
Sort By:
Page
of 44
Molecular Neurodegeneration
|
February 16, 2019
Aberrant deposition of stress granule-resident proteins linked to C9orf72-associated TDP-43 proteinopathy
Jeannie Chew, Casey Cook, Tania F Gendron, et al.
Nature Genetics
|
January 24, 2006
Spectrin mutations cause spinocerebellar ataxia type 5
Yoshio Ikeda, Katherine A Dick, Marcy R Weatherspoon, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 18, 2026
Functional Activity of TDP-43: A Direct Biomarker for ALS
Kirti Shila Sonkar, Vito Levi D'Ancona, Jade Cramp, et al.
Brain : a Journal of Neurology
|
April 12, 2024
Apilimod dimesylate in C9orf72 amyotrophic lateral sclerosis: a randomized phase 2a clinical trial
Suma Babu, Katharine A Nicholson, Jeffrey D Rothstein, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
November 10, 2006
Amyotrophic lateral sclerosis 2-deficiency leads to neuronal degeneration in amyotrophic lateral sclerosis through altered AMPA receptor trafficking
Chen Lai, Chengsong Xie, Stefanie G McCormack, et al.
Nature Neuroscience
|
December 10, 2013
Identification of a unique TGF-β-dependent molecular and functional signature in microglia
Oleg Butovsky, Mark P Jedrychowski, Craig S Moore, et al.
The American Journal of Tropical Medicine and Hygiene
|
December 10, 2024
Evaluation of the Performance of Portable Hemoglobinometers at Measuring Hemoglobin and Detecting Anemia in a Periurban Pediatric Population in Lima, Peru
Zach Silverstein, Alicia Alva Mantari, Kimberly Breglio, et al.
Plos One
|
April 25, 2013
Design and initial results of a multi-phase randomized trial of ceftriaxone in amyotrophic lateral sclerosis
James D Berry, Jeremy M Shefner, Robin Conwit, et al.
The Lancet. Neurology
|
October 10, 2014
Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial
Merit E Cudkowicz, Sarah Titus, Marianne Kearney, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 12, 2016
Motor neuron disease, TDP-43 pathology, and memory deficits in mice expressing ALS-FTD-linked UBQLN2 mutations
Nhat T T Le, Lydia Chang, Irina Kovlyagina, et al.
Page
of 44